I'd like it to be true but it's far fetched to me.
I'd like it to be true but it's far fetched to me.
Don't see anything strange in a $0.011 dividend if we consider that at the time of the announcement the share price was $0.02. There's a press release where they mention they were evaluating the possibility of a dividend. Think that was around February-March. Price at that time was $0.15-$0.20.
Most of all. Share count was 129 mil end of June. 100 mil restricted. Only 29 mil would get the divy. Total planned (and paid) divy was like $350,000.
CRGP paid what they planned to pay to DTCC. DTCC couldn't pay to all the shares in the market, 400 mil or more, they checked the due bills and found out the seller was COR. So, cor was debited.
And that's it. Nobody (CRGP, COR, Nobilis, ETrade) expected the special divy rules to kick in except some sleepless investors (you included).
Still don't think CRGP is responsible for the difference in the divy. COR and friends dumped, so they have to cover. Only way CRGP would be responsible is if it was specified as one of the conditions in the note. Nothing was mentioned related to divys in the note.
I think ETrade's strange behavior retaining the divi was because they shorted and/or issued unauthorized shares on their own, on top of the ones from COR and Alpine. DTCC and SST didn't even have those shares in their count. ETrade didn't want to but finally paid the divy after four months.
Calissio Resources Group, Inc. (CRGP) Stock Research Links
IMHO
Always, always do you own DD. Only invest funds you can afford to lose and trust nobody but yourself.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...
Continue Reading
Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....
Continue Reading
Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...
Continue Reading
Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...
Continue Reading
Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...
Continue Reading